APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,125,633 | -84.5% | 82,167 | -62.9% | 0.00% | -83.3% |
Q2 2023 | $20,170,814 | +12.4% | 221,414 | -18.6% | 0.02% | +4.3% |
Q1 2023 | $17,938,282 | +119.5% | 271,957 | +72.0% | 0.02% | +91.7% |
Q4 2022 | $8,174,161 | -27.6% | 158,077 | -4.4% | 0.01% | -25.0% |
Q3 2022 | $11,292,039 | +107.1% | 165,330 | +37.1% | 0.02% | +14.3% |
Q2 2022 | $5,452,000 | +11.8% | 120,572 | +25.6% | 0.01% | +40.0% |
Q1 2022 | $4,878,000 | -0.7% | 96,009 | -7.6% | 0.01% | +11.1% |
Q4 2021 | $4,911,000 | +492.4% | 103,876 | +313.1% | 0.01% | +350.0% |
Q3 2021 | $829,000 | -48.5% | 25,144 | -1.3% | 0.00% | -33.3% |
Q2 2021 | $1,610,000 | +41.2% | 25,481 | -4.1% | 0.00% | +50.0% |
Q1 2021 | $1,140,000 | -24.5% | 26,559 | +0.7% | 0.00% | -33.3% |
Q4 2020 | $1,509,000 | +105.3% | 26,378 | +8.2% | 0.00% | +50.0% |
Q3 2020 | $735,000 | +7.9% | 24,378 | +16.9% | 0.00% | 0.0% |
Q2 2020 | $681,000 | -9.9% | 20,857 | -26.1% | 0.00% | 0.0% |
Q1 2020 | $756,000 | +3.0% | 28,234 | +17.7% | 0.00% | 0.0% |
Q4 2019 | $734,000 | +62.7% | 23,987 | +28.1% | 0.00% | +100.0% |
Q3 2019 | $451,000 | -5.1% | 18,726 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $475,000 | +62.1% | 18,726 | +24.5% | 0.00% | 0.0% |
Q1 2019 | $293,000 | +41.5% | 15,036 | -4.4% | 0.00% | 0.0% |
Q4 2018 | $207,000 | -17.5% | 15,720 | +11.5% | 0.00% | 0.0% |
Q3 2018 | $251,000 | -19.0% | 14,099 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $310,000 | – | 14,099 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |